Startup Licenses UA Invention to Enhance Natural Safeguard Against Skin Cancer and Other Diseases

Tucson, Ariz. – The University of Arizona has licensed two inventions developed in the Department of Chemistry and Biochemistry to startup MCR Therapeutics. The inventors – Drs. Minying Cai and Victor J. Hruby – developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery.Continue reading

Salutaris Medical Devices, Inc. announces first subject treated in a clinical trial investigating the SMD-DA ophthalmic device for the treatment of neovascular Age-related Macular Degeneration (nAMD)

Salutaris Medical Devices, Inc.  announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.Continue reading

SenesTech Announces Patent Issued on Animal Fertility Control

SenesTech, Inc. (NASDAQ: SNES) announced the issuance of its patent on “REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS.”  This intellectual property is a key aspect of ContraPest®, SenesTech’s flagship product that targets the reproductive capabilities of Norway and roof rats . The patent application was filed August 23, 2013, and has been issued on May 3, 2018 with patent number US 9,956,235.
Continue reading